Physician profile
Morgan J Yost
NPI 1457574949
$26,846.39
in general payments reported to CMS, 2019-2025
6 companies · $501 in 2025
The $501 reported for 2025 was more than what 90% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.55 · 2020: $286 · 2022: $25K · 2023: $706 · 2024: $172 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $532 · Food and Beverage: $301 · Consulting Fee: $291 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $532.42 |
| Food and Beverage | $301.04 |
| Consulting Fee | $291.46 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $254.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $24,633.68 | 2019-2025 | Atlantis, X-Smart, Suresmile |
| Patterson Companies, INC. | $899.50 | 2020-2022 | |
| Ultradent Products INC | $532.42 | 2023-2024 | Opalescence |
| Envista Holdings Corporation | $430.37 | 2025 | Harmonize |
| Kerr Corporation | $204.20 | 2023 | Simplishade |
| Nobel Biocare USA | $146.22 | 2020-2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Yost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.